Breast cancer risk similar in oral contraceptives: Study While the research found similar associations between different contraceptives, the overall risk remains low, according to sexual health experts.
Mystery over proposed pharmacy prescribing ‘trials’ NSW pharmacists will be able to side-step the TGA and extend oral contraception by July – but patient safety protections remain unclear.
New antiviral may offer ‘less cumbersome’ COVID treatment option The Chinese-developed oral antiviral reportedly achieves similar outcomes to Paxlovid, but with fewer side effects and drug–drug interactions.
Molnupiravir to be used only as a last resort: Taskforce Advice has changed for the country’s most prescribed COVID-19 oral antiviral, although access via the PBS will remain in place.
Second bivalent booster receives ATAGI recommendation The vaccine will become available in December and is recommended for people who have not had their first or second booster doses.
‘A positive step’: oral antivirals confirmed for Doctor’s Bag After extensive RACGP lobbying, GPs now have enhanced access to COVID-19 oral antiviral treatments for urgent use among at-risk patients.
Oral antivirals access opens to more Aboriginal Australians The move will come in with PBS changes from 1 November, which also include a treatment for a rare genetic disease.
Enhanced antivirals access a victory for patients RACGP Vice President Dr Bruce Willett goes behind the scenes of a successful campaign to help GPs supply oral antivirals to at-risk patients.
Push to allow pharmacist prescribing of antivirals flipped on its head A ‘more sensible approach’ would see the lifesaving medications added to the Doctor’s Bag, a prominent GP has said.
Could anticipatory deprescribing allow better COVID treatment? Despite being more effective according to some studies, Paxlovid prescriptions lag Lagevrio, with drug–drug interactions likely to play a part.